During the past decade, Cox Health conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 12 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 9 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cox Health" #1 sponsor was "Boston Scientific Corporation" with 9 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Aravive, Inc." with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "C. R. Bard" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cox Health" #1 collaborator was "Alberta Innovation and Science" with 1 trials as a collaborator, "Atlanta Colon & Rectal Surgery, Atlanta, GA" with 1 trials as a collaborator, "BJC HealthCare, Barnes-Jewish St. Peters Hospital" with 1 trials as a collaborator, "Barmherzig Brueder" with 1 trials as a collaborator and "Bnai Zion Medical Center" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Cox Health" are "Heart Failure" (2 trials), "Acute Coronary Syndromes" (1 trials), "Acute Myocardial Infarction" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials) and "Aortic Valve Stenosis" (1 trials). Many other conditions were trialed in "Cox Health" in a lesser frequency.

Most popular intervention types in "Cox Health" are "Device" (11 trials), "Drug" (7 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "5-Fluorouracil" (1 trials), "ACUITY Spiral Left Ventricular Lead" (1 trials), "ACUITY X4 quadripolar coronary venous lead and RELIANCE 4-FRONT defibrillation lead" (1 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cox Health" are 22 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Cox Health". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Cox Health, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cox Health, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".